105 related articles for article (PubMed ID: 2912555)
1. Excretion and metabolism of mitoxantrone in rabbits.
Richard B; Fabre G; Fabre I; Cano JP
Cancer Res; 1989 Feb; 49(4):833-7. PubMed ID: 2912555
[TBL] [Abstract][Full Text] [Related]
2. Interspecies variability in mitoxantrone metabolism using primary cultures of hepatocytes isolated from rat, rabbit and humans.
Richard B; Fabre G; De Sousa G; Fabre I; Rahmani R; Cano JP
Biochem Pharmacol; 1991 Jan; 41(2):255-62. PubMed ID: 1989635
[TBL] [Abstract][Full Text] [Related]
3. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW
J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109
[TBL] [Abstract][Full Text] [Related]
4. Clinical pharmacology of mitoxantrone.
Ehninger G; Proksch B; Heinzel G; Woodward DL
Cancer Treat Rep; 1986 Dec; 70(12):1373-8. PubMed ID: 3791250
[TBL] [Abstract][Full Text] [Related]
5. Biliary excretion of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) and metabolites by Fischer 344 rats.
Musser SM; Egorin MJ; Zuhowski EG; Hamburger DR; Parise RA; Covey JM; White KD; Eiseman JL
Cancer Chemother Pharmacol; 2003 Aug; 52(2):139-46. PubMed ID: 12761648
[TBL] [Abstract][Full Text] [Related]
6. Isolation and structure elucidation of urinary metabolites of mitoxantrone.
Blanz J; Mewes K; Ehninger G; Proksch B; Greger B; Waidelich D; Zeller KP
Cancer Res; 1991 Jul; 51(13):3427-33. PubMed ID: 2054783
[TBL] [Abstract][Full Text] [Related]
7. Metabolism and disposition of menogaril (NSC 269148) in the rabbit.
Dodion P; Egorin MJ; Engisch KL; Bachur NR
Cancer Res; 1985 Nov; 45(11 Pt 1):5352-7. PubMed ID: 2932217
[TBL] [Abstract][Full Text] [Related]
8. Cytochrome P-450-induced cytotoxicity of mitoxantrone by formation of electrophilic intermediates.
Mewes K; Blanz J; Ehninger G; Gebhardt R; Zeller KP
Cancer Res; 1993 Nov; 53(21):5135-42. PubMed ID: 8221649
[TBL] [Abstract][Full Text] [Related]
9. Metabolism of cyclosporin A. I. Study in freshly isolated rabbit hepatocytes.
Fabre G; Bertault-Peres P; Fabre I; Maurel P; Just S; Cano JP
Drug Metab Dispos; 1987; 15(3):384-90. PubMed ID: 2886316
[TBL] [Abstract][Full Text] [Related]
10. Metabolism of isotretinoin. Biliary excretion of isotretinoin glucuronide in the rat.
Meloche S; Besner JG
Drug Metab Dispos; 1986; 14(2):246-9. PubMed ID: 2870901
[TBL] [Abstract][Full Text] [Related]
11. Biliary elimination and hepatic disposition of an association of piperacillin and tazobactam: experimental evaluation.
Brogard JM; Caro-Sampara F; Westphal JF; Blickle JF; Jehl F
Drugs Exp Clin Res; 1994; 20(6):247-55. PubMed ID: 7758397
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and biliary excretion of mitoxantrone in rats.
Yang X; Morris ME
J Pharm Sci; 2010 May; 99(5):2502-10. PubMed ID: 20013854
[TBL] [Abstract][Full Text] [Related]
13. New aspects on the pharmacokinetics of mitoxantrone and its two major metabolites.
Schleyer E; Kamischke A; Kaufmann CC; Unterhalt M; Hiddemann W
Leukemia; 1994 Mar; 8(3):435-40. PubMed ID: 8127148
[TBL] [Abstract][Full Text] [Related]
14. Clinical pharmacokinetics of 5-fluorouracil and its metabolites in plasma, urine, and bile.
Heggie GD; Sommadossi JP; Cross DS; Huster WJ; Diasio RB
Cancer Res; 1987 Apr; 47(8):2203-6. PubMed ID: 3829006
[TBL] [Abstract][Full Text] [Related]
15. Hepatic clearance of gitoxin. Metabolism and biliary excretion by rabbit isolated liver.
Pellegrin PL; Lesne M
Drug Metab Dispos; 1984; 12(2):235-41. PubMed ID: 6144490
[TBL] [Abstract][Full Text] [Related]
16. The absorption, distribution, metabolism and excretion of rofecoxib, a potent and selective cyclooxygenase-2 inhibitor, in rats and dogs.
Halpin RA; Geer LA; Zhang KE; Marks TM; Dean DC; Jones AN; Melillo D; Doss G; Vyas KP
Drug Metab Dispos; 2000 Oct; 28(10):1244-54. PubMed ID: 10997947
[TBL] [Abstract][Full Text] [Related]
17. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 1st communication: absorption, concentrations in plasma, metabolism, and excretion after single administration to rats and dogs.
Boberg M; Ahr HJ; Beckermann B; Bühner K; Siefert HM; Steinke W; Wünsche C; Hirayama M
Arzneimittelforschung; 1997 Aug; 47(8):928-38. PubMed ID: 9296279
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of mitoxantrone in man and laboratory animals.
Batra VK; Morrison JA; Woodward DL; Siverd NS; Yacobi A
Drug Metab Rev; 1986; 17(3-4):311-29. PubMed ID: 3552542
[TBL] [Abstract][Full Text] [Related]
20. Hepatobiliary metabolism and urinary excretion of 4-demethoxydaunorubicin as compared to daunorubicin in rats.
Catapano CV; Guaitani A; Broggini M; Corada M; Bartosek I; Italia C; Donelli MG
Anticancer Res; 1988; 8(4):725-31. PubMed ID: 3178163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
